121/425US=39 / Patologia
Bethel CR, De Marzo AM, Nelson WG. Molecular pathogenesis of prostate cancer: somatic, epigenetic, and genetic alterations. In: Coleman WB, Tsongalis GJ. Molecular pathology: the molecular basis of human disease. Amsterdam: Elsevier, 2009. p. 489-500. ISBN 978-0-12-374419-7.

CANCER DE PROSTATA; PATOGENESE MOLECULAR; CANCER DE PROSTATA. FATORES HEREDITARIOS; EXPRESSAO GENICA; EPIGENETICA

122/425US=47 / Urologia
Reuber L, Cady JO. Overview. In: Hogle WP. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 1-6. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA. EPIDEMIOLOGIA; PROSTATA. ANATOMIA; PROSTATA. FISIOLOGIA; CANCER DE PROSTATA. APRESENTACAO CLINICA

123/425US=47 / Urologia
Cady JO. Prostate cancer diagnosis and staging. In: Hogle WP. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 7-18. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA. INCIDENCIA; CANCER DE PROSTATA. MORTALIDADE; CANCER DE PROSTATA. DIAGNOSTICO; CANCER DE PROSTATA. ESTADIAMENTO

124/425US=47 / Urologia
Hogle WP. Prostate cancer screening, risk, prevention, and prognosis. In: ___. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 19-34. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA. TRIAGEM; CANCER DE PROSTATA. FATORES DE RISCO; CANCER DE PROSTATA. PREVENCAO; CANCER DE PROSTATA. PROGNOSTICO

125/425US=47 / Urologia
Haas ML, Wood SY. Treatment modalities for prostate cancer. In: Hogle WP. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 35-54. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA. TRATAMENTO; VIGILANCIA ATIVA DO CANCER DE PROSTATA; MANIPULACAO HORMONAL; TRATAMENTO CIRURGICO; CIRURGIA; QUIMIOTERAPIA; RADIOTERAPIA

126/425US=47 / Urologia
Moore S. Nursing implications of prostate cancer. In: Hogle WP. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 55-85. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA; ENFERMAGEM; MANIPULACAO HORMONAL; CIRURGIA; QUIMIOTERAPIA; RADIACAO

127/425US=47 / Urologia
Fortenbaugh C. Survivorship issues in prostate cancer. In: Hogle WP. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 87-104. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA; MANIPULACAO HORMONAL; QUIMIOTERAPIA; RADIOTERAPIA; CIRURGIA; QUALIDADE DE VIDA; CUIDADOS PALIATIVOS

128/425US=47 / Urologia
Gosselin TK. Nursing research contributions to the care of patients with prostate cancer. In: Hogle WP. Prostate cancer. Pittsburgh: Oncology Nursing Society, 2009. p. 105-13. (Site-Specific Cancer Series) ISBN 978-1-890504-77-9.

CANCER DE PROSTATA; ENFERMAGEM; PESQUISA; PROMOCAO DE SAUDE; CANCER DE PROSTATA. DIAGNOSTICO; CANCER DE PROSTATA. TRATAMENTO; SINTOMAS; EFEITOS COLATERAIS; PESQUISA PSICOSSOCIAL E COMPORTAMENTAL; FAMILIA

129/425US=50 / Câncer
Priceman SJ, Burton JB, Wu L. Functional molecular imaging of prostate cancer lymph node metastases: adenovirus-mediated lymph node detection. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 177-88. ISBN 978-1-60327-086-1.

IMAGIOLOGIA MOLECULAR FUNCIONAL DO CANCER DE PROSTATA METASTASES LINFONODAIS: ADENOVIRUS; LINFONODO; METASTASE; PET; LUCIFERASE; TERAPIA GENICA

130/425US=50 / Câncer
Li H, Tang DG. Prostate cancer stem cells and their involvement in metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 455-61. ISBN 978-1-60327-086-1.

CANCER DE PROSTATA. CELULAS-TRONCO; CANCER DE PROSTATA; CELULAS-TRONCO DO CANCER; TUMORAIS CELULAS PROGENITORAS; METASTASE; CELULAS ESTAMINAIS METASTATICO

131/425US=50 / Câncer
Ryan CJ. Development in the management of genitourinary malignancies: prostate cancer and renal cell carcinoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 533-44. ISBN 978-1-60327-086-1.

DOENCAS MALIGNAS DO APARELHO GENITURINARIO; CANCER DE PROSTATA; CARCINOMA DE CELULAS RENAIS; CASTRACAO-RESISTENTE O CANCER DE PROSTATA; ANDROGENIOS ADRENAIS; IMUNOTERAPIA; FASE II; ABIRATERONA; ATRASENTAN; BEVACIZUMAB; CALCITRIOL; QUIMIOTERAPIA; GVAX; IPILIMUMAB; IXABEPILONA; SATRAPLATIN; SIPULEUCEL-T; VEGF; SUNITINIB; SORAFENIB

132/425US=60 / Biol/Mol
Dinnen RD, Petrylak DP, Fine RL. Strategies to circumvent resistance to apoptosis in prostate cancer cells by targeted necrosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 327-46. ISBN 978-1-4020-9596-2.

APOPTOSE; MORTE CELULAR PROGRAMADA; RESISTENCIA A APOPTOSE; CANCER DE PROSTATA; NECROSE; P53; ESPECIES REATIVAS DE OXIGENIO

133/425US=64 / Biol/Mol
Franklin RB, Costello LC. Citrate metabolism in prostate and cancers. In: Singh KK, Costello LC. Mitochondria and cancer. New York: Spriger, 2009. p. 61-78. ISBN 978-0-387-84834-1.

METABOLISMO DE CITRATO NA PROSTATA E CANCER; PAPEIS METABOLICOS DE CITRATO; CELULAS DE MAMIFEROS; CITRATO DE CANCER DE PROSTATA; ZINCO E METABOLISMO MITOCONDRIAL; AXIMS DE RELACOES DE ATIVIDADE CELULAR; METABOLISMO CITRATO DE CELULAS EPITELIAIS DA PROSTATA NORMAIS; RELACAO CITRATO ALTERADAS NO CANCER DE PROSTATA; PAPEL DA GLICOLISE ACELERADA NO METABOLISMO DA CELULA TUMORAL

134/425US=87 / Biol/Mol
Foye A, Febbo PG. Cancer gene profiling in prostate cancer. In: Grützmann R, Pilarsky C. Cancer gene profiling: methods and protocols. New York: Humana Press, 2009. p. 293-326. (Methods in Molecular Biology, 576) ISBN 978-1-934115-76-3.

CANCER DE PROSTATA; ANALISE DE EXPRESSAO; MICRODISSECCAO A LASER DE CAPTURA; ANALISE EM BLOCO

135/425US=96 / Biol/Mol
Zhy YS, Imperato-McGinley JL. 5&*945;-Reductase isozymes and androgenic actions in the prostate. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 43-56. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

5&*945;-REDUTASE ISOZIMAS E ACCOES ANDROGENICOS NA PROSTATA; 5&*945;-REDUTASE; 5&*945;RD; RECEPTOR DE ANDROGENO; AR; RECEPTOR DE ESTROGENO; ER; HIPERPLASIA BENIGNA DA PROSTATA; BPH; CANCER DE PROSTATA; ANTIGENO PROSTATICO ESPECIFICO; PSA; EXPRESSAO DO GENE

136/425US=96 / Biol/Mol
Ellem SJ, Risbridger GP. The dual, opposing roles of estrogen in the prostate. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 174-86. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; PROSTATA; AROMATASE; PROSTATITE; ER-&*945;; ER-ß

137/425US=96 / Biol/Mol
Cocciadiferro L, Miceli V, Kang KS, Polito LM, Trosko JE, Carruba G. Profiling cancer stem cells in androgen-responsive and refractory human prostate tumor cell lines. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 257-62. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CELULAS-TRONCO DO CANCER; CANCER DE PROSTATA; MARCADORES DE CELULAS-TRONCO; DIFERENCIACAO MARCADORES DE CELULAS; METABOLISMO ANDROGENICO

138/425US=96 / Biol/Mol
Pandini G, Genua M, Frasca F, Vigneri R, Belfiore A. Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathaway. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 263-7. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE PROSTATA; ESTROGENIO ANDROGENO FATOR DE CRESCIMENTO SEMELHANTE A INSULINA; IGF-1 RECEPTOR

139/425US=96 / Biol/Mol
Balistreri CR, Carruba G, Calabrò M, Campisi I, Di Carlo D, Lio D, Colonna-Romano G, Candore G, Caruso C. CCR5 proinflammatory allele in prostate cancer risk. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 289-92. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

CANCER DE PROSTATA; INFLAMACAO; CCR5&*916;32 EXCLUSAO

140/425US=16-A / Estatística
Williams H, Powell IJ. Epidemiology, pathology, and genetics of prostate cancer among african americans compared with other ethnicities. In: Verma M. Cancer epidemiology. New York: Humana Press, 2009. p. 439-53. (Methods in Molecular Biology, 472) ISBN 978-1-60327-491-3.

EPIDEMIOLOGIA; RESULTADO DE PROSTATA CANCER; DIFERENCAS RACIAIS; GENETICA

Primeira | Anterior | Próxima | Última